Hyruan (sodium hyaluronate) / LG Chem - LARVOL DELTA

LG Chem targets Chinese knee osteoarthritis market with hyaluronic acid injection (Korea Biomedical Review) - "LG Chem said it plans to enter the Chinese osteoarthritis treatment market by launching its one-time hyaluronic acid (HA) injection therapy, Synovian (Chinese name: Hyruan ONE), in collaboration with its Chinese partner Yifan Pharmaceutical. According to market research firm IQVIA, the Chinese HA injection market for osteoarthritis is valued at approximately 200 billion won ($144.1 million), making it the third-largest globally after the U.S. and Japan."

Launch non-US • Immunology • Osteoarthritis • Pain

The Efficacy of Ultrasound-guided Hydrodilatation With Hyaluronic Acid for Patients With Adhesive Capsulitis (clinicaltrials.gov) - P=N/A | N=62 | Completed | Sponsor: Taipei Veterans General Hospital, Taiwan | Recruiting ➔ Completed

Trial completion

Effects of Knee Injections on Patients With Knee Osteoarthritis (clinicaltrials.gov) - P4 | N=60 | Enrolling by invitation | Sponsor: Taipei Medical University

New P4 trial • Immunology • Osteoarthritis • Pain • Rheumatology

The Efficacy of Ultrasound-guided Hydrodilatation With Hyaluronic Acid for Patients With Adhesive Capsulitis (clinicaltrials.gov) - P=N/A; N=76; Recruiting; Sponsor: Taipei Veterans General Hospital, Taiwan; Trial primary completion date: Dec 2018 ➔ Dec 2020

Clinical • Trial primary completion date